Cite

HARVARD Citation

    Graham, J. et al. (n.d.). Neoadjuvant FOLFIRINOX treatment for borderline resectable pancreatic ductal adenocarcinoma: The pathological implications. HPB. pp. e5-e6. [Online]. 
  
Back to record